Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR)7224 (M.P., L.N., C.M.-L., K.R., V.G.-M., S.M.-K.), Inserm 952 (M.P., L.N., C.M.-L., K.R., V.G.-M., S.M.-K.), and Physiopathologie des Maladies du Système Nerveux Central (M.P., L.N., C.M.-L., K.R., V.G.-M., S.M.-K.), Université Pierre et Marie Curie, F-75005 Paris, France; Institut National de la Recherche Agronomique UMR85 Physiologie de la Reproduction et des Comportements (M.M., I.F., M.K.) and CNRS UMR7247 (M.M., I.F., M.K.), F-37380 Nouzilly, France; and Université François Rabelais (M.M., I.F., M.K.), F-37000 Tours, France.
Endocrinology. 2014 Feb;155(2):502-12. doi: 10.1210/en.2013-1639. Epub 2013 Nov 21.
There are human reproduction concerns associated with extensive use of bisphenol A (BPA)-containing plastic and, in particular, the leaching of BPA into food and beverages. In this context, it remains unclear whether and how exposure to BPA interferes with the developmental organization and adult activation of male sexual behavior by testosterone. We evaluated the developmental and adult exposure to oral BPA at doses equivalent to the no-observed-adverse-effect-level (5 mg/kg body weight per day) and tolerable daily intake (TDI) (50 μg/kg body weight per day) on mouse sexual behavior and the potential mechanisms underlying BPA effects. Adult exposure to BPA reduced sexual motivation and performance at TDI dose only. Exposed males took longer to initiate mating and reach ejaculation despite normal olfactory chemoinvestigation. This deficiency was not restored by sexual experience and was associated with unchanged circulating levels of testosterone. By contrast, developmental exposure to BPA at TDI or no-observed-adverse-effect-level dose did not reduce sexual behavior or alter the neuroanatomical organization of the preoptic area. Disrupting the neural androgen receptor resulted in behavioral and neuroanatomical effects similar to those induced by adult exposure to TDI dose. Moreover, adult exposure of mutant males to BPA at TDI dose did not trigger additional alteration of sexual behavior, suggesting that BPA and neural androgen receptor mutation share a common mechanism of action. This shows, for the first time, that the neural circuitry underlying male sexual behavior is vulnerable to chronic adult exposure to low dose of BPA and suggests that BPA could act in vivo as an antiandrogenic compound.
人们对广泛使用含有双酚 A(BPA)的塑料以及 BPA 浸出到食物和饮料中对人类生殖系统的影响表示担忧。在此背景下,尚不清楚接触 BPA 是否以及如何干扰睾酮对雄性性行为的发育组织和成年激活。我们评估了口服 BPA 的发育和成年暴露,剂量相当于无观察到不良作用水平(每天 5mg/kg 体重)和可耐受日摄入量(TDI)(每天 50μg/kg 体重)对雄性动物性行为的影响,以及 BPA 作用的潜在机制。TDI 剂量的 BPA 暴露仅降低了成年雄性的性动机和性行为表现。暴露的雄性尽管嗅觉化学探测正常,但交配开始和射精所需的时间更长。这种缺陷不能通过性经验恢复,并且与循环睾酮水平不变有关。相比之下,TDI 或无观察到不良作用水平剂量的发育暴露不会降低性行为或改变视前区的神经解剖组织。破坏神经雄激素受体导致的行为和神经解剖学效应与 TDI 剂量的成年暴露诱导的相似。此外,突变雄性成年暴露于 TDI 剂量的 BPA 不会引发性行为的额外改变,这表明 BPA 和神经雄激素受体突变具有共同的作用机制。这首次表明,雄性性行为的神经回路易受慢性低剂量 BPA 暴露的影响,并表明 BPA 可能在体内作为一种抗雄激素化合物发挥作用。